Army phase II proposal A2-6834 titled "miniature, point-of-care device for establishing sterile connections in combat environments"

Ended Definitive Contract Awarded Last action

Contract number
W81XWH18C0003
Awardee
Awarding agency
Obligated
$999,743

Award facts

Opportunity
  • HQ003417R2ASB Solicitation number
Contract value 100% obligated
$999,742.97 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
Pricing
Fixed Price Level of Effort
Place of performance
Danvers, MA 01923, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 · Gama therapeutics' army 16.1 sbir phase II medical r & d contract from proposal A2-6834 for "miniature, point-of-care device for establishing sterile… $0
Funding Only Action P00003 · Incremental funding to fully fund gama therapeutics, LLC's army sbir phase II medical r & d contract for usaisr for "miniature, point-of-care device for… $527,714
Novation Agreement P00002 · Novation to recognize gama therapeutics, LLC as the transferee in interest, from remphos technologies, LLC, of the army 16.1 sbir PH II for "miniature,… $0
Change Order P00001 · Change in scope for army 16.1 sbir phase II effort under proposal A2-6834. $0
Original award $472,028

About this award

The Department of the Army Medical Command awarded a $999,742.97 Small Business Innovation Research (SBIR) Phase II contract to Gama Therapeutics LLC, a for-profit organization, for the development of a "Miniature, Point-of-Care Device for Establishing Sterile Connections in Combat Environments." The contract was awarded on December 8, 2017, with a completion date of October 7, 2020. This fixed-price level of effort contract was awarded under the SBIR program, which provides funding to small businesses for research and development.

Quick answers

Who was awarded contract W81XWH18C0003?

W81XWH18C0003 was awarded to Gama Therapeutics LLC by Medical Command (Department of the Army) on December 8, 2017.

How much is contract W81XWH18C0003 worth?

The government has obligated $999,743 on W81XWH18C0003.

Was contract W81XWH18C0003 competed?

The extent of competition for W81XWH18C0003 was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award